Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis

OBJECTIVES: To assess the therapeutic response to brolucizumab and aflibercept by deep learning/OCT-based analysis of macular fluid volumes in neovascular age-related macular degeneration. METHODS: In this post-hoc analysis of two phase III, randomised, multi-centre studies (HAWK/HARRIER), 1078 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt-Erfurth, Ursula, Mulyukov, Zufar, Gerendas, Bianca S., Reiter, Gregor S., Lorand, Daniel, Weissgerber, Georges, Bogunović, Hrvoje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101971/
https://www.ncbi.nlm.nih.gov/pubmed/35523860
http://dx.doi.org/10.1038/s41433-022-02077-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101971/
https://www.ncbi.nlm.nih.gov/pubmed/35523860
http://dx.doi.org/10.1038/s41433-022-02077-4

Ejemplares similares